EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Lysine Methyltransferase SETDB1 Alleviates Methionine- and Choline-Deficient Diet-Induced Steatohepatitis by Suppressing Ferroptosis

Dong Yang, Yuan Deng, Chang-Qing Yin, Wang Kang, Chun-Qing Song

Journal of Biological Chemistry · 2026-10 · 113665

DOI: 10.1016/j.jbc.2026.113665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026-10. Verfasst von Dong Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China; Key Laboratory of Growth Regulation and Translational Research of Zhejiang Provin…. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent chronic liver disorder, with its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), characterized by steatosis, inflammation, hepatocyte injury, and fibrosis. However, the underlying mechanism remains incompletely understood. Here, we performed an in vivo CRISPR screen in Cas9 mice fed a methionine- and choline-deficient (MCD) diet to identify epigenetic regulators of MASH. SETDB1 emerged as a key modulator: hepatocyte-specific loss of Setdb1 exacerbated steatosis, inflammation, ductular reaction, and fibrosis, whereas Setdb1 overexpression markedly alleviated these pathological features. Notably, human liver samples showed decreased SETDB1 expression with advancing MASLD. Furthermore, SETDB1 deficiency increased hepatic ferroptosis by upregulating ACSL4, aggravating MASH pathology, whereas ACSL4 knockout reduced liver injury in the absence of SETDB1. SETDB1 overexpression protected against liver damage by repressing ACSL4. Therefore, the SETDB1-ACSL4-ferroptosis axis regulates MASH progression and represents a potential therapeutic target.

Schlagwörter

Stichwörter der Autor:innen

ACSL4In vivo CRISPR screenMCD-induced MASHSETDB1ferroptosis

Autor:innen und Institutionen

  • School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China; Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang,…
  • Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China; Westlake Laboratory of Life Sciences and Biomedicine, Hangzho…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yang, D., Deng, Y., Yin, C. Q., Kang, W., & Song, C. Q. (2026). The Lysine Methyltransferase SETDB1 Alleviates Methionine- and Choline-Deficient Diet-Induced Steatohepatitis by Suppressing Ferroptosis. Journal of Biological Chemistry, 113665. https://doi.org/10.1016/j.jbc.2026.113665

Vancouver

Yang D, Deng Y, Yin CQ, Kang W, Song CQ. The Lysine Methyltransferase SETDB1 Alleviates Methionine- and Choline-Deficient Diet-Induced Steatohepatitis by Suppressing Ferroptosis. Journal of Biological Chemistry. 2026:113665. doi:10.1016/j.jbc.2026.113665

BibTeX
@article{Yang2026,
  author = {Yang, Dong and Deng, Yuan and Yin, Chang-Qing and Kang, Wang and Song, Chun-Qing},
  title = {The Lysine Methyltransferase SETDB1 Alleviates Methionine- and Choline-Deficient Diet-Induced Steatohepatitis by Suppressing Ferroptosis},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  pages = {113665},
  doi = {10.1016/j.jbc.2026.113665}
}
Kostenlos starten →